Skip to content

Drug interactions

Buprenorphine subdermal implant + Safinamide

Severity: Major

Buprenorphine subdermal implant and Safinamide: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Buprenorphine has serotonergic activity and co-use with MAO inhibitors may cause serotonin syndrome or opioid toxicity. Risk is greater at initiation and dose changes.

What this interaction means in plain words

Buprenorphine subdermal implant and Safinamide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Low

Why it happens

Additive serotonergic effects with MAO-B inhibition and possible potentiation of opioid effects.

What to do

Avoid if possible. If used, monitor for agitation, tremor, hyperthermia and sedation, and remove the implant and treat if serotonin syndrome occurs.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine subdermal implant and Safinamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Buprenorphine subdermal implant with Safinamide?

MediHelp rates the interaction as major. Buprenorphine subdermal implant and Safinamide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Buprenorphine has serotonergic activity and co-use with MAO inhibitors may cause serotonin syndrome or opioid toxicity. Risk is greater at initiation and dose changes.

How serious is the interaction between Buprenorphine subdermal implant and Safinamide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible. If used, monitor for agitation, tremor, hyperthermia and sedation, and remove the implant and treat if serotonin syndrome occurs.

What other medicines interact with Safinamide?

MediHelp also lists interactions of Safinamide with, for example, Amitriptyline, Amoxapine, Amphetamine polistirex. The full list is on the Safinamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in